Literature DB >> 21389792

Trends in incidence, management, and survival of gastric and cardia carcinomas in the area of Finistere (France) between 1984 and 2003.

Julien Jézéquel1, Christophe Bessaguet, Cedric Verveur, Joseph Faycal, Zoe Richert, Jean-Philippe Metges, Alain Volant, Jean-Baptiste Nousbaum, Michel Robaszkiewicz.   

Abstract

OBJECTIVE: The aim of this study was to evaluate trends in incidence and prognosis of gastric and cardia carcinomas in the area of Finistère (France) between 1984 and 2003.
METHODS: The Digestive Tumor Registry of Finistère recorded all new cases of gastric and cardia carcinomas from January 1, 1984 to December 31, 2003. Raw incidence data were standardized using the direct method based on the reference world population. The data and survival rates were studied in univariate and multivariate analyses.
RESULTS: Between 1984-1988 and 1999-2003 the standardized incidence of distal gastric carcinomas decreased (10.74 ± 0.39-5.68 ± 0.27/year/100 000 inhabitants, P < 0.001). There was no significant increase in the incidence of cardia carcinomas (0.83 ± 0.11-1.25 ± 0.14/year/100 000 inhabitants). The frequency of macroscopically infiltrating tumors doubled (P < 0.001) and linitis plastica increased from 9 to 16.2% (P < 0.001). Overall survival rates increased only for patients with metastatic carcinomas of both locations (P < 0.001) and with advanced tumors of distal stomach (P < 0.001) receiving therapy.
CONCLUSION: This study showed a significant decrease over time in the incidence of distal gastric carcinomas but no significant increase in the incidence of cardia carcinomas. Despite improvement in the management of patients, prognosis remains dismal, probably because of an increased incidence of poor prognosis of histological and anatomical types.

Entities:  

Mesh:

Year:  2010        PMID: 21389792     DOI: 10.1097/MEG.0b013e3283408865

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  6 in total

1.  Outcomes of surgical treatment for gastric cancer patients: 11-year experience of a Chinese high-volume hospital.

Authors:  Wei-Han Zhang; Xin-Zu Chen; Kai Liu; Xiao-Long Chen; Kun Yang; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Med Oncol       Date:  2014-08-12       Impact factor: 3.064

2.  Trends in gastric cancer incidence: a period and birth cohort analysis in a well-defined French population.

Authors:  Chapelle Nicolas; Manfredi Sylvain; Lepage Come; Faivre Jean; Bouvier Anne-Marie; Jooste Valérie
Journal:  Gastric Cancer       Date:  2015-06-29       Impact factor: 7.370

3.  Incidence trends and mortality rates of gastric cancer in Israel.

Authors:  Ron Lavy; Andronik Kapiev; Natan Poluksht; Ariel Halevy; Lital Keinan-Boker
Journal:  Gastric Cancer       Date:  2012-04-24       Impact factor: 7.370

4.  Epidemiological profile of gastric cancer in the northwestern region of Algeria: about 116 cases.

Authors:  Safia Fehim; Racheda Bouhaous; Mustapha Diaf; Amine Mokhtar Drici; Meghit Boumediene Khaled
Journal:  J Gastrointest Oncol       Date:  2017-08

5.  Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer.

Authors:  E A Korkeila; T Salminen; R Kallio; M Mikkola; P Auvinen; S Pyrhönen; R Ristamäki
Journal:  Support Care Cancer       Date:  2017-04-20       Impact factor: 3.603

6.  Differential Expression of Genes Involved in Metabolism and Immune Response in Diffuse and Intestinal Gastric Cancers, a Pilot Ptudy.

Authors:  Martine Perrot-Applanat; Cynthia Pimpie; Sophie Vacher; Ivan Bieche; Marc Pocard; Véronique Baud
Journal:  Biomedicines       Date:  2022-01-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.